e-Article
S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL PHASE 2 STUDY TIDAL
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 109-110 (2022)
Subject
Language
English
ISSN
2572-9241